相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Selective Tau Imaging: Der Stand der Dinge
Victor L. Villemagne
JOURNAL OF NUCLEAR MEDICINE (2018)
Tau imaging with [18F]THK-5351 in progressive supranuclear palsy
A. Ishiki et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer's Disease with Positron Emission Tomography
Luca C. Gobbi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau Imaging
Lieven Declercq et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Tau PET imaging: present and future directions
Laure Saint-Aubert et al.
MOLECULAR NEURODEGENERATION (2017)
Cryo-EM structures of tau filaments from Alzheimer's disease
Anthony W. P. Fitzpatrick et al.
NATURE (2017)
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
Kok Pin Ng et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography
Laetitia Lemoine et al.
SCIENTIFIC REPORTS (2017)
[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
Marta Marquie et al.
ACTA NEUROPATHOLOGICA (2017)
In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings
Benjamin Hall et al.
AGEING RESEARCH REVIEWS (2017)
Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies
Maiko Ono et al.
BRAIN (2017)
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
Ryuichi Harada et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease
Tetsuro Tago et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Preclinical Evaluation of [18F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer
Tetsuro Tago et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain
Lisheng Cai et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias
Kerstin Sander et al.
ALZHEIMERS & DEMENTIA (2016)
Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351
Ryuichi Harada et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
Eric D. Hostetler et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET
Akio Kikuchi et al.
NEUROLOGY (2016)
Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807
Lieven Declercq et al.
MOLECULAR IMAGING (2016)
An autoradiographic evaluation of AV-1451 Tau PET in dementia
Val J. Lowe et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Characteristics of Tau and Its Ligands in PET Imaging
Ryuichi Harada et al.
BIOMOLECULES (2016)
T807, a reported selective tau tracer, binds with nanomolar affinity to monoamine oxidase a
Céline Vermeiren et al.
Alzheimers & Dementia (2015)
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
Marta Marquie et al.
ANNALS OF NEUROLOGY (2015)
Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue
Laetitia Lemoine et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Chun-Fang Xia et al.
ALZHEIMERS & DEMENTIA (2013)
Amyloid Fibril-Induced Structural and Spectral Modifications in the Thioflavin-T Optical Probe
N. Arul Murugan et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2013)
Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
Masahiro Maruyama et al.
NEURON (2013)
A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies
Wei Zhang et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies
Paul W. Thompson et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]
Ana Velasco et al.
FEBS LETTERS (2008)
分享论文
